NIO shares accelerated in Hong Kong after the Chinese electric-vehicle maker reported its first-ever quarterly profit and gave strong guidance. The company's stock was recently 16% higher after rising ...

A now-erased post from Chris Wright whipsawed crude for the second-straight session. IEA Proposes Largest Ever Oil Release From Strategic Reserves Countries would decide Wednesday whether to release ...

Dow Jones Top Company Headlines at 11 PM ET: Oracle Raises 2027 Sales View as AI Demand Outpaces Supply | OpenAI ... The cloud-computing company posted a profit of $3.72 billion and raised its fiscal ...

Wharf REIC's flagship properties are Harbour City and Times Square, which are well-known destinations for locals and tourists alike. Historically, the two properties collectively account for around 8% ...

More recently, OCI’s strong client focus and ability to scale put it squarely at the center of the booming AI ecosystem, leading to skyrocketing bookings with key AI stakeholders such as OpenAI, Meta, ...

In polling released Tuesday, Ottawa-based Nanos Research suggested 46% of voters would back the Liberals, followed by 33% for the Conservatives, and 10% for the New Democrats. Pollsters and political ...

For the first time in over a decade and a half, Oracle says it grew both revenue and earnings by at least 20% Oracle's stock was rising after Tuesday's earnings report. Oracle proved the ...

Amazon's debt issuance comes as no surprise to GimmeCredit analyst Carol Levenson, who estimates that Amazon could require up to $83 billion in incremental debt this year to support its elevated ...

Panic in the oil market has calmed down, but wealthy nations still can't release enough crude in reserves to offset lost Middle East barrels Panic in the oil market has calmed down, but wealthy ...

A now-erased post from Chris Wright whipsawed crude for the second-straight session. Record Diesel-Price Surge Hits U.S. Truckers, Retailers and Manufacturers The average on-highway price for diesel ...

Kalydeco, Orkambi, Symdeko, Trikafta, and Alyftrek—make the firm eligible to treat about 90% of the CF population. We expect Vertex to maintain its dominant position in CF, given the strong efficacy ...